Application of response surface methodology to maximize the productivity of scalable automated human embryonic stem cell manufacture
Aim: Commercial regenerative medicine will require large quantities of clinical-specification human cells. The cost and quality of manufacture is notoriously difficult to control due to highly complex processes with poorly defined tolerances. As a step to overcome this, we aimed to demonstrate the u...
|Main Authors:||, , , , ,|
No Tags, Be the first to tag this record!